JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2025. Vol. 70. № 5
DOI:10.33266/1024-6177-2025-70-5-28-35
E.A. Kodintseva1, A.А. Akleyev2
The Contribution of Effector Cells of the Innate and Adaptive Immunity to the Pathogenesis of Radiation-Induced Carcinogenesis. Review (Part 2)
1 Urals Research Center for Radiation Medicine, Chelyabinsk, Russia
2 Southern-Urals State Medical University, Chelyabinsk, Russia
Contact person: E.A. Kodintseva, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
CONTENTS
Background
1. Cooperation of innate and adaptive immunity cells in pathogenesis in carcinogenesis
2. Neutrophilic granulocytes and cytotoxic T-lymphocytes
3. Neutrophils and antigen-presenting cells
4. Associations of immunocompetent cells with circulating tumor cells
5. Neutrophils and natural killers
6. Tumor microenvironment and angiogenesis
7. Effect of ionizing radiation on innate immunity cells in the tumor microenvironment
8. Ionizing radiation effects modulating the tumor microenvironment
9. The effect of radiation treatment on macrophages and myeloid-derived suppressor cells of the tumor microenvironment
Conclusion
Keywords: peripheral blood cells, radiation exposure, carcinogenesis, innate immunity, adaptive immunity, intercellular cooperation, radiosensitivity
For citation: Kodintseva EA, Akleyev AА. The Contribution of Effector Cells of the Innate and Adaptive Immunity to the Pathogenesis of Radiation-Induced Carcinogenesis. Review (Part 2). Medical Radiology and Radiation Safety. 2025;70(5):28–35. (In Russian). DOI:10.33266/1024-6177-2025-70-5-28-35
References
1 Lee M.S., Kim Y.J. Signaling Pathways Downstream of Pattern-Recognition Receptors and their Cross Talk. Annual Review Biochemistry. 2007;76:447-480. doi: 10.1146/annurev.biochem.76.060605.122847.
2. Свитич О.А., Филина А.Б., Давыдова Н.В., Ганковская Л.В., Зверев В.В. Роль факторов врожденного иммунитета в процессе опухолеобразования // Медицинская иммунология. 2018. Т.20. №2. С. 151-162 [Svitich O.A., Filina A.B., Davydova N.V., Gankovskaya L.V., Zverev V.V. The Role of Innate Immunity Factors in the Process of Tumor Formation. Meditsinskaya Immunologiya = Medical Immunology. 2018;20;2:151-162 (In Russ.)]. doi: 10.15789/1563-0625-2018-2-151-162.
3. Wang L., Lankhorst L., Bernards R. Exploiting Senescence for the Treatment of Cancer. Nature Reviews Cancer. 2022;22:340-355. doi: 10.1038/s41568-022-00450-9.
4. Jarosz-Biej M., Smolarczyk R., Cicho´n T., Kułach N. Tumor Microenvironment as a “Game Changer” in Cancer Radiotherapy. International Journal of Molecular Sciences. 2019;20;13:1-19. doi: 10.3390/ijms20133212.
5. Cui Y., Guo G. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment. International Journal of Molecular Sciences. 2016;17:1942. doi: 10.3390/ijms17111942.
6. Albini A., Bruno A., Noonan D.M., Mortara L. Contribution to Tumor Angiogenesis from Innate Immune Cells within the Tumor Microenvironment: Implications for Immunotherapy. Frontiers in Immunology. 2018;9:527. doi: 10.3389/fimmu.2018.00527.
7. El Alaoui-Lasmaili K., Faivre B. Antiangiogenic Therapy: Markers of Response, “Normalization” and Resistance. Critical Reviews in Oncology/Hematology. 2018;128:118-129. doi: 10.1016/j.critrevonc.2018.06.001.
8. Klein D. The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy. Frontiers in Oncology. 2018;8:367. doi: 10.3389/fonc.2018.00367.
9. Shevtsov M., Sato H., Multhoff G., Shibata A. Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy. Frontiers in Oncology. 2019;9:156. doi: 10.3389/fonc.2019.00156.
10. Ballesteros I., Rubio-Ponce A., Genua M., Lusito E., Kwok I., Fernández-Calvo G., Khoyratty T.E., van Grinsven E., González-Hernández S., Nicolás-Ávila J.Á., Vicanolo T., Maccataio A., Benguría A., Li J.L., Adrover J.M., Aroca-Crevillen A., Quintana J.A., Martín-Salamanca S., Mayo F., Ascher S., Barbiera G., Soehnlein O., Gunzer M., Ginhoux F., Sánchez-Cabo F., Nistal-Villán E., Schulz C., Dopazo A., Reinhardt C., Udalova I.A., Ng L.G., Ostuni R., Hidalgo A. Co-Option of Neutrophil Fates by Tissue Environments. Cell. 2020;183:1282-1297. doi: 10.1016/j.cell.2020.10.003.
11. Guo B., Oliver T.G. Partners in Crime: Neutrophil–CTC Collusion in Metastasis. Trends in Immunology. 2019;40;7:556-559. doi: 10.1016/j.it.2019.04.009.
12. Jaeger B.N., Donadieu J., Cognet C., Bernat C., Ordoñez-Rueda D., Barlogis V., Mahlaoui N., Fenis A., Narni-Mancinelli E., Beaupain B., Bellanné-Chantelot C., Bajénoff M., Malissen B., Malissen M., Vivier E., Ugolini S. Neutrophil Depletion Impairs Natural Killer Cell Maturation, Function, and Homeostasis. Journal of Experimental Medicine. 2012;209:565-580. doi: 10.1084/jem.20111908.
13. Shaul M.E. Fridlender Z.G. Tumour-Associated Neutrophils in Patients with Cancer. Nature Reviews Clinical Oncology. 2019;16:601-620. doi: 10.1038/s41571-019-0222-4.
14. Valayer A., Brea D., Lajoie L., Avezard L., Combes-Soia L., Labas V., Korkmaz B., Thibault G., Baranek T., Si-Tahar M. Neutrophils can Disarm NK Cell Response through Cleavage of NKp46. Journal of Leukocyte Biology. 2017;101:253-259. doi: 10.1189/jlb.3AB0316-140RR.
15. Liang W., Ferrara N. The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis. Cancer Immunology Research. 2016;4:83-91. doi: 10.1158/2326-6066.CIR-15-0313.
16. Li P., Lu M., Shi J., Hua L., Hua L., Gong Z., Li Q., Shultz L.D., Ren G. Dual Roles of Neutrophils in Metastatic Colonization are Governed by the Host NK Cell Status. Nature Communications. 2020;11:4387. doi: 10.1038/s41467-020-18125-0.
17. Jensen K.N., Omarsdottir S.Y., Reinhardsdottir M.S., Hardardottir I., Freysdottir J. Docosahexaenoic acid Modulates NK Cell Effects on Neutrophils and their Crosstalk. Frontiers in Immunology. 2020;11:570380. doi: 10.3389/fimmu.2020.570380.
18. Tsai C.Y., Hsieh S.C., Liu C.W., Lu C.S., Wu C.H., Liao H.T., Chen M.H., Li K.J., Shen C.Y., Kuo Y.M., Yu C.L. Cross-Talk among Polymorphonuclear Neutrophils, Immune, and Non-Immune Cells via Released Cytokines, Granule Proteins, Microvesicles, and Neutrophil Extracellular Trap Formation: a Novel Concept of Biology and Pathobiology for Neutrophils. International Journal of Molecular Sciences. 2021;22:3119. doi: 10.3390/ijms22063119.
19. Khatami M. Chronic Inflammation: Synergistic Interactions of Recruiting macropHages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis! Cancers (Basel). 2014;6:297-322. doi: 10.3390/cancers6010297.
20. Engblom C., Pfirschke C., Pittet M.J. The Role of Myeloid Cells in Cancer Therapies. Nature Reviews Cancer. 2016;16;7:447-462. doi: 10.1038/nrc.2016.54.
21. Hekim N., Cetin Z., Nikitaki Z., Cort A., Saygili E.I. Radiation Triggering Immune Response and Inflammation. Cancer Letters. 2015;368:156-163. doi: 10.1016/j.canlet.2015.04.016.
22. Chajon E., Castelli J., Marsiglia H., De Crevoisier R. The Synergistic Effect of Radiotherapy and Immunotherapy: a Promising but not Simple Partnership. Critical Reviews in Oncology/Hematology. 2017;111:124-132. doi: 10.1016/j.critrevonc.2017.01.017.
23. McKelvey K.J., Hudson A.L., Back M., Eade T., Diakos C.I. Radiation, Inflammation and the Immune Response in Cancer. Mammalian Genome. 2018;29:843-865. doi: 10.1007/s00335-018-9777-0.
24. Manda K., Glasow A., Paape D., Hildebrandt G. Effects of Ionizing Radiation on the Immune System with Special Emphasis on the Interaction of Dendritic and T Cells. Frontiers in Oncology. 2012;2:102. doi: 10.3389/fonc.2012.00102.
25. Persa E., Balogh A., Safrany G., Lumniczky K. The Effect of Ionizing Radiation on Regulatory T Cells in Health and Disease. Cancer Letters. 2015;368:252-261. doi: 10.1016/j.canlet.2015.03.003.
26. Rubner Y., Wunderlich R., Rühle P.F., Kulzer L., Werthmöller N., Frey B., Weiss E.M., Keilholz L., Fietkau R., Gaipl U.S. How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity? Frontiers in Oncology. 2012;2:75. doi: 10.3389/fonc.2012.00075.
27. Deloch L., Derer A., Hartmann J., Frey B., Fietkau R., Gaipl U.S. Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation. Frontiers in Oncology. 2016;6:141. doi: 10.3389/fonc.2016.00141.
28. Frey B., Rückert M., Deloch L., Rühle P.F., Derer A., Fietkau R., Gaipl U.S. Immunomodulation by Ionizing Radiation-Impact for Design of Radio-Immunotherapies and for Treatment of Inflammatory Diseases. Immunological Reviews. 2017;280:231-248. doi: 10.1111/imr.12572.
29. Walle T., Martinez Monge R., Cerwenka A., Ajona D., Melero I., Lecanda F. Radiation Effects on Antitumor Immune Responses: Current Perspectives and Challenges. Therapeutic Advances in Medical Oncology. 2018;10:1758834017742575. doi: 10.1177/1758834017742575.
30. Carvalho H.A., Villar R.C. Radiotherapy and Immune Response: the Systemic Effects of a Local Treatment. Clinics. 2018;73:557. doi: 10.6061/clinics/2018/e557s.
31. Bernier J. Immuno-Oncology: Allying Forces of Radio- and Immuno-Therapy to Enhance Cancer Cell Killing. Critical Reviews in Oncology/Hematology. 2016;108:97-108. doi: 10.1016/j.critrevonc.2016.11.001.
32. Herrera F.G., Bourhis J., Coukos G. Radiotherapy Combination Opportunities Leveraging Immunity for the Next Oncology Practice. CA: a Cancer Journal for Clinicians. 2017;67:65-85. doi: 10.3322/caac.21358.
33. Gandhi S., Chandna S. Radiation-Induced Inflammatory Cascade and its Reverberating Crosstalks as Potential Cause of Post-Radiotherapy Second Malignancies. Cancer Metastasis Reviews. 2017;36:375-393. doi: 10.1007/s10555-017-9669-x.
34. Ma Y., Pitt J.M., Li Q., Yang H. The Renaissance of Anti-Neoplastic Immunity from Tumor Cell Demise. Immunological Reviews. 2017;280:194-206. doi: 10.1111/imr.12586.
35. Bockel S., Durand B., Deutsch E. Combining Radiation Therapy and Cancer Immune Therapies: from Preclinical Findings to Clinical Applications. Cancer Radiotherapie. 2018;22:567-580. doi: 10.1016/j.canrad.2018.07.136.
36. Arnold K.M., Flynn N.J., Raben A., Romak L., Yu Y., Di-
cker A.P., Mourtada F., Sims-Mourtada J. The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Factionation Schedules. Cancer Growth and Metastasis. 2018;11:1179064418761639. doi: 10.1177/1179064418761639.
37. Tsoutsou P.G., Zaman K., Martin Lluesma S., Cagnon L., Kandalaft L., Vozenin M.C. Emerging Opportunities of Radiotherapy Combined with Immunotherapy in the Era of Breast Cancer Heterogeneity. Frontiers in Oncology. 2018;8:609. doi: 10.3389/fonc.2018.00609.
38. Jeong H., Bok S., Hong B.J., Choi H.S., Ahn G.O. Radiation-Induced Immune Responses: Mechanisms and Therapeutic Perspectives. Blood Research. 2016;51:157-163. doi: 10.5045/br.2016.51.3.157.
39. Nguyen H.Q., To N.H., Zadigue P., Kerbrat S., De La Taille A., Le Gouvello S., Belkacemi Y. Ionizing Radiation-Induced Cellular Senescence Promotes Tissue Fibrosis after Radiotherapy. A Review. Critical Reviews in Oncology/Hematology. 2018;129:13-26. doi: 10.1016/j.critrevonc.2018.06.012.
40. Meziani L., Deutsch E., Mondini M. Macrophages in Radiation Injury: a New Therapeutic Target. Oncoimmunology. 2018;7:1494488. doi: 10.1080/2162402X.2018.1494488.
41. Crittenden M.R., Cottam B., Savage T., Nguyen C., Newell P., Gough M.J. Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy. PLoS One. 2012;7:9295. doi: 10.1371/journal.pone.0039295.
42. Tsai C.S., Chen F.H., Wang C.C., Huang H.L., Jung S.M., Wu C.J., Lee C.C., McBride W.H., Chiang C.S., Hong J.H. Macrophages from Irradiated Tumors Express Higher Levels of iNOS, Arginase-I and COX-2, and Promote Tumor Growth. International Journal of Radiation Oncology, Biology, Physics. 2007;68;2:499-507. doi: 10.1016/j.ijrobp.2007.01.041.
43. Okubo M., Kioi M., Nakashima H., Sugiura K., Mitsudo K., Aoki I., Taniguchi H., Tohnai I. M2-Polarized Macrophages Contribute to Neovasculogenesis, Leading to Relapse of Oral Cancer Following Radiation. Scientific Reports. 2016;6:27548. doi: 10.1038/srep27548.
44. Balachandran V.P., Beatty G.L., Dougan S.K. Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities. Gastroenterology. 2019;156;7:2056-2072. doi: 10.1053/j.gastro.2018.12.038.
45. Pinto Т.A., Pinto L.M., Cardoso P.A., Monteiro C., Pinto T.M., Maia F.A., Castro P., Figueira R., Monteiro A., Marques M., Mareel M., Dos Santos S.G., Seruca R., Barbosa A.M., Rocha S., Oliveira J.M. Ionizing Radiation Modulates Human Macrophages Towards a Pro-Inflammatory Phenotype Preserving their Pro-Invasive and Pro-Angiogenic Capacities. Scientific Reports. 2016;6:18765. doi: 10.1038/s41598-022-08498-1.
46. Prakash H., Klug F., Nadella V., Mazumdar V., Schmitz-Winnenthal H., Umansky L. Low Doses of Gamma Irradiation Potentially Modifies Immunosuppressive Tumor Microenvironment by Retuning Tumor-Associated Macrophages: Lesson from Insulinoma. Carcinogenesis. 2016;37;3:301-313. doi: 10.1093/carcin/bgw007.
47. Wu Q., Allouch A., Paoletti A., Leteur C., Mirjolet C., Martins I., Voisin L., Law F., Dakhli H., Mintet E., Thoreau M., Muradova Z., Gauthier M., Caron O., Milliat F., Ojcius D.M., Rosselli F., Solary E., Modjtahedi N., Deutsch E., Perfettini J.L. NOX2-Dependent ATM Kinase Activation Dictates Pro-Inflammatory Macrophage Phenotype and Improves Effectiveness to Radiation Therapy. Cell Death and Differentiation. 2017;24;9:1632-1644. doi: 10.1038/cdd.2017.91.
48. Pinto A.T., Pinto M.L., Velho S., Pinto M.T., Cardoso A.P., Figueira R., Monteiro A., Marques M., Seruca R., Barbosa M.A., Mareel M., Oliveira M.J., Rocha S. Intricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation. PLoS ONE. 2016;11;8:160891. doi: 10.1371/journal.pone.0160891.
49. Klug F., Prakash H., Huber P.E., Seibel T., Bender N., Halama N., Pfirschke C., Voss R.H., Timke C., Umansky L., Klapproth K., Schäkel K., Garbi N., Jäger D., Weitz J., Schmitz-Winnenthal H., Hämmerling G.J., Beckhove P. Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy. Cancer Cell. 2013;24;5:589-602. doi: 10.1016/j.ccr.2013.09.014.
50. Tsukimoto M., Homma T., Mutou Y., Kojima S. 0.5 Gy Gamma Radiation Suppresses Production of TNF-Alpha through Up-Regulation of MKP-1 in Mouse Macrophage RAW264.7 Cells. Radiation Research. 2009;171;2:219-224. doi: 10.1667/RR1351.1.
51. Beyranvand Nejad E., Welters M.J., Arens R., van der Burg S.H. The Importance of Correctly Timing Cancer Immunotherapy. Expert Opinion on Biological Therapy. 2017;17:87-103. doi: 10.1080/14712598.2017.1256388.
52. Wang S.J., Haffty B. Radiotherapy as a Тew Player in Immuno-Oncology. Cancers (Basel). 2018;10:515. doi: 10.3390/cancers10120515.
53. Schaue D., McBride W.H. Opportunities and Challenges of Radiotherapy for Treating Cancer. Nature Reviews Clinical Oncology. 2015;12:527-540. doi: 10.1038/nrclinonc.2015.120.
54. Ostrand-Rosenberg S., Horn L.A., Ciavattone N.G. Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy. Frontiers in Oncology. 2019;9:215. doi: 10.3389/fonc.2019.00215
55. Rückert M., Deloch L., Fietkau R., Frey B., Hecht M., Gaipl U.S. Immune Modulatory Effects of Radiotherapy as Basis for Well-Reasoned Radioimmunotherapies. Strahlentherapie Und Onkologie. 2018;194:509-519. doi: 10.1007/s00066-018-1287-1.
56. Barker H.E., Paget J.T., Khan A.A., Harrington K.J. The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence. Nature Reviews Cancer. 2015;15:409-425. doi: 10.1038/nrc3958.
57. Shi X., Shiao S.L. The Role of Macrophage Phenotype in Regulating the Response to Radiation Therapy. Translational Research. 2018;191:64-80. doi: 10.1016/j.trsl.2017.11.002.
58. Wennerberg E., Lhuillier C., Vanpouille-Box C., Pilones K.A., García-Martínez E., Rudqvist N.P., Formenti S.C., Demaria S. Barriers to Radiation-Induced in Situ Tumor Vaccination. Frontiers in Immunology. 2017;8:229. doi: 10.3389/fimmu.2017.00229.
59. Shen M.J., Xu L.J., Yang L., Tsai Y., Keng P.C., Chen Y., Lee S.O., Chen Y. Radiation Alters PD-L1/NKG2D Ligand Levels in Lung Cancer Cells and Leads to Immune Escape from NK Cell Cytotoxicity Via IL-6-MEK/Erk Signaling Pathway. Oncotarget. 2017;8;46:80506-80520. doi: 10.18632/oncotarget.19193.
60. Jeong S.K., Kim J.S., Yoon S.O., Park Y.S., Kim S.D., Yoon S.O., Han D.H., Lee K.Y., Jeong M.H., Jo W.S. DOI Tumor Associated Macrophages Provide the Survival Resistance of Tumor Cells to Hypoxic Microenvironmental Condition through IL-6 Receptor-Mediated Signals. Immunobiology. 2017;222;1:55-65. doi: 10.1016/j.imbio.2015.11.010.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The research work was carried out within the framework of the state assignment of the Federal Medical and Biological Agency of Russia on the topic ‘Study of the functional state of effector cells of human antitumour immunity during the implementation of carcinogenic effects of chronic radiation exposure’ (Agreement on granting a subsidy from the federal budget for financial provision of the state assignment for public services (works) No. 388-03-2025-085 dated 24 January 2025).
Contribution. All authors confirm that their authorship meets the international ICMJE criteria. Kodintseva Е.А. – conceived and designed the study, prepared the first draft of the article, read and approved the final version before publication. Akleуev А.А. – conceived and designed the study, scientific editing, read and approved the final version before publication.
Article received: 20.05.2025. Accepted for publication: 25.06.2025.